Exact Mass: 685.2285

Exact Mass Matches: 685.2285

Found 21 metabolites which its exact mass value is equals to given mass value 685.2285, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Auramycin C

C35H43NO13 (685.2734)

2,14-Diacetoxy-1-furoyloxydihydro-6-(2-methylbutanoyloxy)-9-nicotinoyloxy-beta-agarofuran

C35H43NO13 (685.2734)

1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-furoyloxy-11-(2-methyl)butyryloxy-4beta-hydroxydihydro-beta-agarofuran|2,6-Diacetoxy-9-furoyloxydihydro-14-(2-methylbutanoyloxy)-1-nicotinoyloxy-beta-agarofuran

1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-furoyloxy-11-(2-methyl)butyryloxy-4beta-hydroxydihydro-beta-agarofuran|2,6-Diacetoxy-9-furoyloxydihydro-14-(2-methylbutanoyloxy)-1-nicotinoyloxy-beta-agarofuran

C35H43NO13 (685.2734)

6-O-methyl-N-deacetyl-6-O-alpha-D-glucopyranosylisoipecosidic acid

C31H43NO16 (685.2582)

3beta-O-propionyl-5alpha,10beta,14beta-tri-O-acetyl-8beta-O-nicotinoylcyclomyrsinol|euphorbialoid G

C35H43NO13 (685.2734)

geodiamolide I

C34H44BrN3O7 (685.2362)

5-({[4-(chloromethyl)phenyl]carbonyl}amino)-2-(1,2,2,4,8,10,10,11-octamethyl-10,11-dihydro-2H-pyrano[3,2-g:5,6-g]diquinolin-1-ium-6-yl)benzoate

C42H40ClN3O4 (685.2707)

Endomorphin 2 TFA, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM[1]. Endomorphin 2 TFA, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM[1].

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C35H43NO13 (685.2734)

1α-nicotinoyloxy-2α-acetoxy-6β-acetoxy-9β-furoyloxy-11-(2-methyl)butyryloxy-4β-hy-droxydihydro-β-agarofuran

C35H43NO13 (685.2734)

{"Ingredient_id": "HBIN002313","Ingredient_name": "1\u03b1-nicotinoyloxy-2\u03b1-acetoxy-6\u03b2-acetoxy-9\u03b2-furoyloxy-11-(2-methyl)butyryloxy-4\u03b2-hy-droxydihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C35H43NO13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15528","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

7-[(3-bromo-4-hydroxyphenyl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadeca-5,11,15-triene-2,9-dione

C34H44BrN3O7 (685.2362)

(4r,7r,10s,13s,15e,17r,19r)-7-[(3-bromo-4-hydroxyphenyl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadeca-5,11,15-triene-2,9-dione

C34H44BrN3O7 (685.2362)

methyl (1r,2r,4s)-4-{[(2r,4s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1r,2r,4s)-4-{[(2r,4s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C35H43NO13 (685.2734)

4,12-bis(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-{[(2-methylbutanoyl)oxy]methyl}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C35H43NO13 (685.2734)

(4s,5r,6s)-5-ethenyl-4-{[(1s)-7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

(4s,5r,6s)-5-ethenyl-4-{[(1s)-7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C31H43NO16 (685.2582)

(1s,2r,3r,4s,5s,7r,8r,9r,10r,11s,12s,14r,15r)-2,8,12-tris(acetyloxy)-7-hydroxy-5,9,12-trimethyl-16-oxo-4-(propanoyloxy)-18-oxapentacyclo[7.7.2.0¹,¹⁰.0³,⁷.0¹¹,¹⁴]octadecan-15-yl pyridine-3-carboxylate

(1s,2r,3r,4s,5s,7r,8r,9r,10r,11s,12s,14r,15r)-2,8,12-tris(acetyloxy)-7-hydroxy-5,9,12-trimethyl-16-oxo-4-(propanoyloxy)-18-oxapentacyclo[7.7.2.0¹,¹⁰.0³,⁷.0¹¹,¹⁴]octadecan-15-yl pyridine-3-carboxylate

C35H43NO13 (685.2734)

(4r,7r,10s,13s,15e,17r,19s)-7-[(3-bromo-4-hydroxyphenyl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadeca-5,11,15-triene-2,9-dione

C34H44BrN3O7 (685.2362)

5-ethenyl-4-[(7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-6-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

5-ethenyl-4-[(7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-6-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C31H43NO16 (685.2582)

methyl (1r,2r,4s)-4-{[(2s,4s,5r,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1r,2r,4s)-4-{[(2s,4s,5r,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C35H43NO13 (685.2734)